| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Glycosylases | 28 | 2020 | 128 | 5.970 |
Why?
|
| DNA Repair | 44 | 2020 | 2046 | 4.090 |
Why?
|
| Guanine | 24 | 2017 | 274 | 3.860 |
Why?
|
| Geobacillus stearothermophilus | 12 | 2017 | 27 | 3.800 |
Why?
|
| DNA | 62 | 2020 | 7301 | 3.350 |
Why?
|
| DNA-Formamidopyrimidine Glycosylase | 17 | 2013 | 18 | 2.970 |
Why?
|
| N-Glycosyl Hydrolases | 23 | 2004 | 68 | 2.930 |
Why?
|
| Escherichia coli Proteins | 19 | 2013 | 1050 | 2.220 |
Why?
|
| Nucleic Acid Conformation | 33 | 2015 | 913 | 2.090 |
Why?
|
| Models, Molecular | 57 | 2020 | 5456 | 1.830 |
Why?
|
| Crystallography, X-Ray | 35 | 2020 | 2011 | 1.790 |
Why?
|
| DNA Damage | 25 | 2020 | 2432 | 1.710 |
Why?
|
| Protein Conformation | 44 | 2020 | 4011 | 1.670 |
Why?
|
| Peptides | 22 | 2024 | 4409 | 1.660 |
Why?
|
| DNA, Bacterial | 12 | 2015 | 1465 | 1.370 |
Why?
|
| Alkenes | 9 | 2011 | 57 | 1.340 |
Why?
|
| Binding Sites | 46 | 2022 | 6114 | 1.270 |
Why?
|
| Bacterial Proteins | 22 | 2015 | 3848 | 1.250 |
Why?
|
| Hydrocarbons | 4 | 2012 | 106 | 1.170 |
Why?
|
| Protein Structure, Secondary | 24 | 2014 | 1246 | 1.140 |
Why?
|
| DNA-Binding Proteins | 38 | 2009 | 9648 | 1.070 |
Why?
|
| Catalysis | 21 | 2013 | 761 | 1.030 |
Why?
|
| Amino Acid Sequence | 52 | 2020 | 13815 | 1.000 |
Why?
|
| Substrate Specificity | 26 | 2015 | 1801 | 0.990 |
Why?
|
| Protein Engineering | 6 | 2017 | 540 | 0.990 |
Why?
|
| Molecular Sequence Data | 64 | 2014 | 18111 | 0.970 |
Why?
|
| Escherichia coli | 22 | 2013 | 4217 | 0.940 |
Why?
|
| Anniversaries and Special Events | 1 | 2024 | 89 | 0.900 |
Why?
|
| Combinatorial Chemistry Techniques | 5 | 2003 | 129 | 0.860 |
Why?
|
| Biology | 1 | 2024 | 294 | 0.800 |
Why?
|
| Molecular Dynamics Simulation | 3 | 2020 | 413 | 0.770 |
Why?
|
| Cytosine | 9 | 2012 | 216 | 0.750 |
Why?
|
| Tacrolimus Binding Protein 1A | 1 | 2020 | 39 | 0.750 |
Why?
|
| Alcohols | 5 | 2003 | 92 | 0.740 |
Why?
|
| Actinobacteria | 1 | 2020 | 56 | 0.720 |
Why?
|
| Base Sequence | 45 | 2012 | 12797 | 0.710 |
Why?
|
| Protein Binding | 36 | 2017 | 9386 | 0.710 |
Why?
|
| Endodeoxyribonucleases | 5 | 2007 | 165 | 0.710 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2020 | 474 | 0.700 |
Why?
|
| Cell-Penetrating Peptides | 2 | 2012 | 44 | 0.690 |
Why?
|
| Transcription Factor AP-1 | 6 | 1998 | 317 | 0.690 |
Why?
|
| Base Pairing | 8 | 2017 | 141 | 0.680 |
Why?
|
| Macrolides | 1 | 2020 | 201 | 0.680 |
Why?
|
| DNA Footprinting | 4 | 2002 | 98 | 0.650 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 13 | 2005 | 85 | 0.650 |
Why?
|
| Genome, Bacterial | 3 | 2020 | 760 | 0.640 |
Why?
|
| Stereoisomerism | 11 | 2017 | 624 | 0.640 |
Why?
|
| Phosphorothioate Oligonucleotides | 1 | 2017 | 10 | 0.630 |
Why?
|
| Cross-Linking Reagents | 12 | 2013 | 694 | 0.610 |
Why?
|
| Receptors, Opioid, mu | 3 | 2003 | 182 | 0.610 |
Why?
|
| IMP Dehydrogenase | 1 | 2017 | 34 | 0.590 |
Why?
|
| Cyclophilin A | 1 | 2017 | 57 | 0.580 |
Why?
|
| Transcription Factors | 28 | 2009 | 12208 | 0.570 |
Why?
|
| Disulfides | 8 | 2005 | 457 | 0.530 |
Why?
|
| ras Proteins | 2 | 2017 | 1060 | 0.520 |
Why?
|
| Protein Structure, Tertiary | 18 | 2010 | 3846 | 0.520 |
Why?
|
| Oligodeoxyribonucleotides | 11 | 2006 | 708 | 0.520 |
Why?
|
| Mutagenesis, Site-Directed | 12 | 2015 | 1723 | 0.520 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2017 | 433 | 0.510 |
Why?
|
| Structure-Activity Relationship | 15 | 2017 | 3129 | 0.510 |
Why?
|
| Recombinant Proteins | 15 | 2017 | 6622 | 0.510 |
Why?
|
| Haemophilus | 3 | 2012 | 27 | 0.500 |
Why?
|
| Small Molecule Libraries | 1 | 2020 | 720 | 0.490 |
Why?
|
| Adenine | 4 | 2010 | 936 | 0.480 |
Why?
|
| DNA-Cytosine Methylases | 2 | 2012 | 17 | 0.480 |
Why?
|
| Molecular Structure | 12 | 2010 | 1899 | 0.470 |
Why?
|
| Circular Dichroism | 6 | 2014 | 354 | 0.470 |
Why?
|
| Transcriptional Activation | 5 | 2009 | 1783 | 0.460 |
Why?
|
| DNA Ligases | 3 | 2003 | 80 | 0.460 |
Why?
|
| Proteins | 7 | 2024 | 6103 | 0.450 |
Why?
|
| Chemistry, Pharmaceutical | 2 | 2009 | 281 | 0.440 |
Why?
|
| beta Catenin | 2 | 2021 | 1059 | 0.440 |
Why?
|
| Adenosine Triphosphatases | 2 | 2007 | 839 | 0.420 |
Why?
|
| RNA | 4 | 2012 | 2749 | 0.420 |
Why?
|
| Nuclear Proteins | 11 | 2009 | 5853 | 0.420 |
Why?
|
| Models, Chemical | 8 | 2013 | 626 | 0.400 |
Why?
|
| Catalytic Domain | 9 | 2015 | 698 | 0.400 |
Why?
|
| Molecular Probes | 2 | 2011 | 316 | 0.390 |
Why?
|
| Leucine Zippers | 5 | 1998 | 117 | 0.390 |
Why?
|
| Bioengineering | 1 | 2011 | 99 | 0.370 |
Why?
|
| Calcineurin | 3 | 2020 | 226 | 0.350 |
Why?
|
| Mutagens | 2 | 2020 | 168 | 0.350 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 2 | 2006 | 93 | 0.340 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 4 | 2004 | 71 | 0.330 |
Why?
|
| Cell Membrane Permeability | 4 | 2012 | 590 | 0.330 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2011 | 2948 | 0.330 |
Why?
|
| Oncogenes | 2 | 2012 | 1265 | 0.330 |
Why?
|
| Wnt Proteins | 1 | 2012 | 721 | 0.320 |
Why?
|
| Ligands | 9 | 2024 | 3282 | 0.320 |
Why?
|
| Transcription Factor TFIID | 2 | 1999 | 151 | 0.320 |
Why?
|
| Fluorenes | 3 | 2007 | 160 | 0.320 |
Why?
|
| Adenosine Diphosphate | 2 | 2007 | 425 | 0.310 |
Why?
|
| Kinetics | 14 | 2013 | 6473 | 0.310 |
Why?
|
| TATA-Binding Protein Associated Factors | 2 | 1999 | 104 | 0.310 |
Why?
|
| Antiviral Agents | 1 | 2020 | 2987 | 0.310 |
Why?
|
| Protein Structure, Quaternary | 4 | 2017 | 436 | 0.300 |
Why?
|
| Nucleosides | 1 | 2007 | 138 | 0.300 |
Why?
|
| Deoxyribonuclease (Pyrimidine Dimer) | 4 | 2003 | 7 | 0.290 |
Why?
|
| Drug Design | 3 | 2009 | 1076 | 0.290 |
Why?
|
| Enzyme Inhibitors | 4 | 2005 | 3798 | 0.290 |
Why?
|
| Telomerase | 1 | 2012 | 730 | 0.290 |
Why?
|
| DNA-Directed DNA Polymerase | 4 | 2020 | 486 | 0.290 |
Why?
|
| Furans | 4 | 2007 | 194 | 0.290 |
Why?
|
| Amino Acids | 3 | 2010 | 1736 | 0.280 |
Why?
|
| DNA Primers | 6 | 2003 | 2892 | 0.280 |
Why?
|
| Nucleotides | 3 | 2008 | 464 | 0.270 |
Why?
|
| Translocation, Genetic | 1 | 2012 | 1420 | 0.270 |
Why?
|
| Drug Discovery | 3 | 2024 | 1058 | 0.270 |
Why?
|
| Hydrogen Bonding | 8 | 2010 | 293 | 0.270 |
Why?
|
| Adenylyl Imidodiphosphate | 1 | 2005 | 19 | 0.270 |
Why?
|
| Jurkat Cells | 4 | 2017 | 743 | 0.270 |
Why?
|
| Drug Delivery Systems | 3 | 2012 | 2219 | 0.260 |
Why?
|
| Deoxyuridine | 2 | 2002 | 33 | 0.260 |
Why?
|
| DNA, Superhelical | 1 | 2005 | 50 | 0.260 |
Why?
|
| Sulfhydryl Compounds | 3 | 2001 | 298 | 0.250 |
Why?
|
| Protein Stability | 4 | 2012 | 557 | 0.250 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 2005 | 121 | 0.250 |
Why?
|
| DNA Gyrase | 1 | 2005 | 83 | 0.250 |
Why?
|
| Mutation | 19 | 2017 | 29786 | 0.250 |
Why?
|
| Trans-Activators | 4 | 2001 | 2924 | 0.250 |
Why?
|
| Directed Molecular Evolution | 1 | 2005 | 160 | 0.250 |
Why?
|
| Molecular Probe Techniques | 2 | 2002 | 119 | 0.240 |
Why?
|
| Zinc | 7 | 2001 | 684 | 0.240 |
Why?
|
| High Mobility Group Proteins | 3 | 2000 | 187 | 0.240 |
Why?
|
| RNA, Bacterial | 1 | 2006 | 390 | 0.240 |
Why?
|
| Chromatography, Affinity | 3 | 1996 | 549 | 0.230 |
Why?
|
| Protein Interaction Mapping | 1 | 2007 | 627 | 0.230 |
Why?
|
| NFATC Transcription Factors | 8 | 2000 | 381 | 0.230 |
Why?
|
| Proto-Oncogene Proteins | 7 | 2004 | 4554 | 0.230 |
Why?
|
| Molecular Conformation | 5 | 2007 | 563 | 0.230 |
Why?
|
| Protein Folding | 7 | 2017 | 843 | 0.230 |
Why?
|
| Saccharomyces cerevisiae Proteins | 3 | 1998 | 1888 | 0.220 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 3920 | 0.220 |
Why?
|
| DNA Methylation | 7 | 2012 | 4286 | 0.220 |
Why?
|
| Cytidine Deaminase | 1 | 2005 | 252 | 0.220 |
Why?
|
| Static Electricity | 4 | 2008 | 267 | 0.220 |
Why?
|
| Thermus thermophilus | 1 | 2002 | 19 | 0.220 |
Why?
|
| Azepines | 1 | 2005 | 336 | 0.220 |
Why?
|
| NF-kappa B | 8 | 1999 | 2499 | 0.220 |
Why?
|
| Cloning, Molecular | 8 | 2006 | 4320 | 0.220 |
Why?
|
| Methylation | 8 | 2006 | 1106 | 0.210 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 6 | 2003 | 1801 | 0.210 |
Why?
|
| Saccharomyces cerevisiae | 6 | 1999 | 2752 | 0.210 |
Why?
|
| DNA Helicases | 1 | 2007 | 859 | 0.210 |
Why?
|
| HIV Reverse Transcriptase | 2 | 2000 | 213 | 0.210 |
Why?
|
| Enzymes | 1 | 2004 | 266 | 0.210 |
Why?
|
| Metals | 3 | 1996 | 719 | 0.210 |
Why?
|
| Peptide Mapping | 2 | 2007 | 263 | 0.210 |
Why?
|
| Silanes | 1 | 2001 | 28 | 0.200 |
Why?
|
| Crystallization | 5 | 2012 | 524 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2007 | 1434 | 0.200 |
Why?
|
| Dimerization | 6 | 2007 | 893 | 0.200 |
Why?
|
| Floxuridine | 1 | 2000 | 49 | 0.200 |
Why?
|
| Sequence Homology, Amino Acid | 11 | 2006 | 2839 | 0.190 |
Why?
|
| Receptors, Transferrin | 1 | 2002 | 296 | 0.190 |
Why?
|
| Transcription, Genetic | 7 | 2012 | 7722 | 0.190 |
Why?
|
| Aspartic Acid | 1 | 2003 | 576 | 0.190 |
Why?
|
| Oligopeptides | 2 | 2003 | 1189 | 0.180 |
Why?
|
| Sequence Homology | 1 | 2020 | 203 | 0.180 |
Why?
|
| HeLa Cells | 5 | 2014 | 3128 | 0.180 |
Why?
|
| Humans | 79 | 2021 | 744343 | 0.180 |
Why?
|
| Amides | 1 | 2022 | 459 | 0.180 |
Why?
|
| Uracil-DNA Glycosidase | 5 | 2004 | 31 | 0.180 |
Why?
|
| Oxidoreductases, O-Demethylating | 1 | 1999 | 4 | 0.170 |
Why?
|
| Thermodynamics | 5 | 2009 | 596 | 0.170 |
Why?
|
| Oligonucleotides | 3 | 2017 | 572 | 0.170 |
Why?
|
| Biocatalysis | 2 | 2009 | 167 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-jun | 5 | 1998 | 286 | 0.170 |
Why?
|
| Amino Acid Substitution | 6 | 2009 | 1791 | 0.170 |
Why?
|
| Adenosine Triphosphate | 1 | 2005 | 2025 | 0.170 |
Why?
|
| Hypocreales | 1 | 2018 | 4 | 0.160 |
Why?
|
| Tyrosine | 1 | 2003 | 1461 | 0.160 |
Why?
|
| Nucleotidyltransferases | 1 | 2020 | 220 | 0.160 |
Why?
|
| Amino Acid Motifs | 3 | 2007 | 936 | 0.160 |
Why?
|
| Signal Transduction | 4 | 2017 | 23403 | 0.160 |
Why?
|
| Protein Multimerization | 3 | 2017 | 970 | 0.160 |
Why?
|
| Carbon-Oxygen Lyases | 1 | 1997 | 8 | 0.160 |
Why?
|
| Amines | 2 | 1997 | 276 | 0.160 |
Why?
|
| Cyclosporins | 1 | 2018 | 220 | 0.160 |
Why?
|
| Herpes Simplex Virus Protein Vmw65 | 1 | 1997 | 28 | 0.160 |
Why?
|
| Point Mutation | 4 | 2013 | 1623 | 0.150 |
Why?
|
| Ribonuclease H | 1 | 2017 | 45 | 0.150 |
Why?
|
| Recombinant Fusion Proteins | 7 | 2001 | 3772 | 0.150 |
Why?
|
| Staphylococcus aureus | 1 | 2006 | 1451 | 0.150 |
Why?
|
| Cryptococcus neoformans | 1 | 2018 | 119 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 4 | 2002 | 6171 | 0.150 |
Why?
|
| Drug Stability | 1 | 2017 | 291 | 0.150 |
Why?
|
| Protein Transport | 3 | 2012 | 1988 | 0.150 |
Why?
|
| DNA, Viral | 4 | 2008 | 2225 | 0.150 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2023 | 1861 | 0.150 |
Why?
|
| Cyclization | 2 | 2010 | 65 | 0.150 |
Why?
|
| Pyrrolidines | 2 | 1998 | 342 | 0.140 |
Why?
|
| Histones | 2 | 2006 | 2599 | 0.140 |
Why?
|
| Ribosome Inactivating Proteins, Type 1 | 1 | 2016 | 27 | 0.140 |
Why?
|
| Spiro Compounds | 1 | 2017 | 76 | 0.140 |
Why?
|
| Tacrolimus Binding Proteins | 3 | 2005 | 195 | 0.140 |
Why?
|
| Arginine | 2 | 1998 | 944 | 0.140 |
Why?
|
| Conserved Sequence | 5 | 2007 | 1202 | 0.140 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2017 | 407 | 0.140 |
Why?
|
| Carrier Proteins | 4 | 2004 | 5021 | 0.140 |
Why?
|
| Autoantigens | 1 | 2020 | 892 | 0.130 |
Why?
|
| Multigene Family | 2 | 1996 | 1102 | 0.130 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2017 | 246 | 0.130 |
Why?
|
| HIV Integrase | 2 | 2007 | 120 | 0.130 |
Why?
|
| Databases, Protein | 1 | 2017 | 383 | 0.130 |
Why?
|
| Mitomycins | 4 | 1987 | 47 | 0.130 |
Why?
|
| K562 Cells | 1 | 2017 | 634 | 0.130 |
Why?
|
| Models, Genetic | 2 | 2002 | 3494 | 0.130 |
Why?
|
| Herpesvirus 1, Human | 1 | 2000 | 743 | 0.130 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2012 | 503 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 6 | 2007 | 5867 | 0.120 |
Why?
|
| DNA, Single-Stranded | 1 | 1996 | 354 | 0.120 |
Why?
|
| Eukaryotic Cells | 1 | 1996 | 198 | 0.120 |
Why?
|
| X-Ray Diffraction | 2 | 2012 | 420 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2011 | 380 | 0.120 |
Why?
|
| Lactones | 1 | 2017 | 329 | 0.120 |
Why?
|
| Mutagenesis, Insertional | 2 | 1997 | 655 | 0.120 |
Why?
|
| Mutagenesis | 5 | 2005 | 1266 | 0.120 |
Why?
|
| Binding, Competitive | 3 | 2009 | 1157 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-rel | 5 | 1997 | 71 | 0.120 |
Why?
|
| Animals | 26 | 2017 | 168757 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-fos | 4 | 1998 | 575 | 0.120 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 5 | 2001 | 507 | 0.120 |
Why?
|
| Biotechnology | 1 | 2016 | 281 | 0.120 |
Why?
|
| Lac Operon | 1 | 1994 | 238 | 0.120 |
Why?
|
| Phosphoproteins | 4 | 1996 | 2440 | 0.120 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 2 | 2006 | 294 | 0.120 |
Why?
|
| HEK293 Cells | 2 | 2020 | 4204 | 0.120 |
Why?
|
| Viral Proteins | 3 | 2008 | 1900 | 0.110 |
Why?
|
| Molecular Mimicry | 3 | 2004 | 201 | 0.110 |
Why?
|
| Antifungal Agents | 1 | 2018 | 730 | 0.110 |
Why?
|
| Templates, Genetic | 4 | 2000 | 211 | 0.110 |
Why?
|
| Sirolimus | 1 | 2020 | 1564 | 0.110 |
Why?
|
| Mutant Proteins | 2 | 2017 | 500 | 0.110 |
Why?
|
| Biological Products | 3 | 2012 | 860 | 0.110 |
Why?
|
| Flow Cytometry | 2 | 2014 | 5974 | 0.110 |
Why?
|
| Peptide Fragments | 4 | 2011 | 5097 | 0.110 |
Why?
|
| Evolution, Molecular | 2 | 2020 | 1940 | 0.110 |
Why?
|
| Fluorouracil | 1 | 1997 | 1619 | 0.110 |
Why?
|
| Methyltransferases | 1 | 1995 | 367 | 0.100 |
Why?
|
| Synchrotrons | 1 | 2012 | 38 | 0.100 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2006 | 670 | 0.100 |
Why?
|
| Magnetic Resonance Spectroscopy | 9 | 2002 | 3760 | 0.100 |
Why?
|
| Receptors, Progesterone | 1 | 1996 | 1097 | 0.100 |
Why?
|
| Molecular Chaperones | 1 | 1996 | 742 | 0.100 |
Why?
|
| Cysteine | 6 | 2001 | 874 | 0.100 |
Why?
|
| Borohydrides | 2 | 2003 | 32 | 0.100 |
Why?
|
| Sequence Alignment | 4 | 2000 | 2256 | 0.100 |
Why?
|
| Schiff Bases | 2 | 2003 | 21 | 0.100 |
Why?
|
| Fungal Proteins | 1 | 1995 | 912 | 0.100 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2020 | 2109 | 0.100 |
Why?
|
| Azacitidine | 1 | 1992 | 347 | 0.100 |
Why?
|
| Transition Temperature | 1 | 2010 | 36 | 0.100 |
Why?
|
| Protein Biosynthesis | 3 | 1994 | 2126 | 0.100 |
Why?
|
| Half-Life | 1 | 2012 | 661 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 4 | 2007 | 6314 | 0.090 |
Why?
|
| Biological Therapy | 1 | 2012 | 138 | 0.090 |
Why?
|
| Methionine | 1 | 2013 | 590 | 0.090 |
Why?
|
| Alanine | 2 | 2006 | 572 | 0.090 |
Why?
|
| Oxidation-Reduction | 4 | 1998 | 2187 | 0.090 |
Why?
|
| Forecasting | 2 | 2016 | 2951 | 0.090 |
Why?
|
| Lysine | 2 | 2006 | 1007 | 0.090 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1994 | 1097 | 0.090 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2017 | 1692 | 0.090 |
Why?
|
| Models, Biological | 3 | 2013 | 9583 | 0.090 |
Why?
|
| Mercury | 3 | 1989 | 285 | 0.090 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 2 | 2006 | 92 | 0.090 |
Why?
|
| Cricetinae | 2 | 2003 | 2472 | 0.080 |
Why?
|
| Antineoplastic Agents | 2 | 2007 | 13695 | 0.080 |
Why?
|
| Genetic Vectors | 2 | 2000 | 3420 | 0.080 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 3462 | 0.080 |
Why?
|
| Organomercury Compounds | 1 | 1988 | 16 | 0.080 |
Why?
|
| Restriction Mapping | 4 | 1994 | 878 | 0.080 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2009 | 154 | 0.080 |
Why?
|
| Pharmaceutical Preparations | 1 | 1996 | 1071 | 0.080 |
Why?
|
| Ubiquitination | 2 | 2023 | 1012 | 0.080 |
Why?
|
| Protein Kinases | 1 | 1995 | 1640 | 0.080 |
Why?
|
| Genotype | 1 | 2002 | 12951 | 0.080 |
Why?
|
| Cell Line | 7 | 2007 | 15997 | 0.070 |
Why?
|
| Computer Simulation | 4 | 2009 | 6196 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 2916 | 0.070 |
Why?
|
| Base Pair Mismatch | 3 | 2003 | 97 | 0.070 |
Why?
|
| Exodeoxyribonucleases | 1 | 2008 | 180 | 0.070 |
Why?
|
| Receptor, Notch1 | 1 | 2009 | 502 | 0.070 |
Why?
|
| Tacrolimus | 3 | 2001 | 743 | 0.070 |
Why?
|
| Deoxyribonuclease I | 3 | 1997 | 229 | 0.070 |
Why?
|
| Neoplasms | 4 | 2017 | 21683 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 8301 | 0.070 |
Why?
|
| Plasmids | 3 | 2005 | 2307 | 0.070 |
Why?
|
| Cell Proliferation | 3 | 2017 | 10481 | 0.070 |
Why?
|
| HIV Long Terminal Repeat | 1 | 2005 | 88 | 0.070 |
Why?
|
| beta-Galactosidase | 2 | 1997 | 573 | 0.070 |
Why?
|
| Genes, bcl-2 | 1 | 2006 | 122 | 0.070 |
Why?
|
| Zinc Fingers | 1 | 2007 | 585 | 0.070 |
Why?
|
| Regulon | 1 | 2005 | 69 | 0.070 |
Why?
|
| DNA Topoisomerase IV | 1 | 2005 | 41 | 0.070 |
Why?
|
| Gene Amplification | 1 | 1990 | 1063 | 0.070 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2006 | 295 | 0.070 |
Why?
|
| Antibodies | 2 | 2012 | 2460 | 0.060 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 9734 | 0.060 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2007 | 689 | 0.060 |
Why?
|
| Leukemia, Experimental | 1 | 2004 | 246 | 0.060 |
Why?
|
| Electrons | 1 | 2005 | 268 | 0.060 |
Why?
|
| Pentoxyl | 1 | 2003 | 1 | 0.060 |
Why?
|
| Cytomegalovirus | 1 | 2008 | 732 | 0.060 |
Why?
|
| Deoxyguanosine | 3 | 1997 | 84 | 0.060 |
Why?
|
| Adenosine Deaminase | 1 | 2006 | 241 | 0.060 |
Why?
|
| Formic Acid Esters | 1 | 2003 | 1 | 0.060 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2016 | 3386 | 0.060 |
Why?
|
| Glutamine | 2 | 2005 | 578 | 0.060 |
Why?
|
| Sulfur Radioisotopes | 1 | 2003 | 116 | 0.060 |
Why?
|
| Mice | 11 | 2017 | 81183 | 0.060 |
Why?
|
| Borrelia burgdorferi | 1 | 2005 | 180 | 0.060 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 2003 | 87 | 0.060 |
Why?
|
| Vaccinia virus | 1 | 2005 | 349 | 0.060 |
Why?
|
| Iron-Sulfur Proteins | 1 | 2003 | 82 | 0.060 |
Why?
|
| Multiprotein Complexes | 2 | 2006 | 1119 | 0.060 |
Why?
|
| Asparagine | 1 | 2003 | 122 | 0.060 |
Why?
|
| Protein Denaturation | 1 | 2003 | 237 | 0.050 |
Why?
|
| Receptors, Opioid, delta | 1 | 2002 | 47 | 0.050 |
Why?
|
| Enzyme Stability | 1 | 2003 | 210 | 0.050 |
Why?
|
| Sequence Deletion | 2 | 1997 | 1526 | 0.050 |
Why?
|
| Radioligand Assay | 1 | 2003 | 374 | 0.050 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2003 | 102 | 0.050 |
Why?
|
| HIV-1 | 3 | 2007 | 6939 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2000 | 1572 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2017 | 21827 | 0.050 |
Why?
|
| Glutamic Acid | 2 | 2009 | 1169 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 3 | 1998 | 1341 | 0.050 |
Why?
|
| Nucleoside Deaminases | 1 | 2001 | 58 | 0.050 |
Why?
|
| Hydrolysis | 1 | 2003 | 682 | 0.050 |
Why?
|
| Cytokines | 1 | 1996 | 7322 | 0.050 |
Why?
|
| Interleukin-2 | 3 | 1998 | 1904 | 0.050 |
Why?
|
| Quantum Theory | 1 | 2001 | 70 | 0.050 |
Why?
|
| Time Factors | 3 | 2010 | 40075 | 0.050 |
Why?
|
| Deoxyribonuclease IV (Phage T4-Induced) | 2 | 1997 | 9 | 0.050 |
Why?
|
| Leucine | 1 | 2003 | 561 | 0.050 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2002 | 144 | 0.050 |
Why?
|
| Peptide Library | 1 | 2022 | 349 | 0.050 |
Why?
|
| Microscopy, Atomic Force | 1 | 2002 | 250 | 0.050 |
Why?
|
| Siloxanes | 1 | 2000 | 27 | 0.050 |
Why?
|
| Guinea Pigs | 1 | 2003 | 1386 | 0.050 |
Why?
|
| Rats | 1 | 2017 | 24260 | 0.050 |
Why?
|
| Isomerism | 1 | 2000 | 201 | 0.050 |
Why?
|
| Apoptosis | 3 | 2006 | 9727 | 0.050 |
Why?
|
| Nucleic Acid Heteroduplexes | 1 | 2000 | 47 | 0.050 |
Why?
|
| Dipeptides | 1 | 2002 | 409 | 0.050 |
Why?
|
| Xenopus Proteins | 2 | 2003 | 433 | 0.050 |
Why?
|
| Thymine DNA Glycosylase | 1 | 1999 | 9 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2016 | 3309 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2012 | 2727 | 0.050 |
Why?
|
| CHO Cells | 1 | 2003 | 1406 | 0.050 |
Why?
|
| Temperature | 2 | 2018 | 2206 | 0.050 |
Why?
|
| Ubiquitins | 1 | 2021 | 384 | 0.040 |
Why?
|
| Base Composition | 2 | 1997 | 293 | 0.040 |
Why?
|
| Models, Structural | 2 | 1997 | 361 | 0.040 |
Why?
|
| Gene Expression | 4 | 1996 | 7799 | 0.040 |
Why?
|
| HMGA1a Protein | 1 | 1999 | 64 | 0.040 |
Why?
|
| Vertebrates | 2 | 2001 | 227 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2006 | 2915 | 0.040 |
Why?
|
| Insect Proteins | 1 | 2000 | 258 | 0.040 |
Why?
|
| Dinucleoside Phosphates | 1 | 1999 | 74 | 0.040 |
Why?
|
| Gene Expression Regulation | 5 | 1999 | 12072 | 0.040 |
Why?
|
| NF-kappa B p50 Subunit | 2 | 1996 | 107 | 0.040 |
Why?
|
| Multienzyme Complexes | 1 | 2002 | 686 | 0.040 |
Why?
|
| Deoxyribonucleosides | 1 | 1997 | 7 | 0.040 |
Why?
|
| Affinity Labels | 1 | 1998 | 109 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 2 | 2002 | 4803 | 0.040 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2016 | 5442 | 0.040 |
Why?
|
| Ethylamines | 1 | 1997 | 15 | 0.040 |
Why?
|
| Deoxyadenosines | 1 | 1997 | 27 | 0.040 |
Why?
|
| Glycosylation | 2 | 1998 | 1126 | 0.040 |
Why?
|
| Phosphates | 1 | 2001 | 786 | 0.040 |
Why?
|
| Nature | 1 | 1996 | 15 | 0.040 |
Why?
|
| Hot Temperature | 1 | 2003 | 1354 | 0.040 |
Why?
|
| Bacteria | 1 | 1988 | 2114 | 0.040 |
Why?
|
| Xenopus | 1 | 1999 | 712 | 0.040 |
Why?
|
| Photochemistry | 2 | 1994 | 238 | 0.040 |
Why?
|
| Immunogenetic Phenomena | 1 | 2016 | 23 | 0.040 |
Why?
|
| DNA, Fungal | 1 | 1998 | 280 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2005 | 4186 | 0.040 |
Why?
|
| Genetic Enhancement | 1 | 2016 | 18 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2006 | 1903 | 0.040 |
Why?
|
| Edetic Acid | 1 | 1996 | 276 | 0.040 |
Why?
|
| Genes, Fungal | 1 | 1998 | 455 | 0.040 |
Why?
|
| Transcription Factor RelB | 1 | 1996 | 29 | 0.030 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 1996 | 109 | 0.030 |
Why?
|
| Organophosphorus Compounds | 1 | 1997 | 215 | 0.030 |
Why?
|
| Biological Transport | 1 | 2001 | 2118 | 0.030 |
Why?
|
| Ribosome Inactivating Proteins | 1 | 1995 | 7 | 0.030 |
Why?
|
| Ricin | 1 | 1995 | 72 | 0.030 |
Why?
|
| Sulfhydryl Reagents | 1 | 1995 | 32 | 0.030 |
Why?
|
| Esters | 1 | 1996 | 210 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1994 | 1085 | 0.030 |
Why?
|
| Immunotoxins | 1 | 2016 | 179 | 0.030 |
Why?
|
| Cerebellum | 1 | 2003 | 1488 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2000 | 1730 | 0.030 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 1998 | 615 | 0.030 |
Why?
|
| Globins | 1 | 1996 | 415 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 1995 | 377 | 0.030 |
Why?
|
| RNA, Small Nuclear | 1 | 1994 | 65 | 0.030 |
Why?
|
| Genes, Bacterial | 2 | 1989 | 1079 | 0.030 |
Why?
|
| Genes | 2 | 1989 | 1893 | 0.030 |
Why?
|
| Gene Targeting | 1 | 1998 | 880 | 0.030 |
Why?
|
| DNA Adducts | 1 | 1994 | 93 | 0.030 |
Why?
|
| Spliceosomes | 1 | 1994 | 110 | 0.030 |
Why?
|
| Photoaffinity Labels | 1 | 1994 | 86 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 1996 | 595 | 0.030 |
Why?
|
| Indicators and Reagents | 2 | 1993 | 462 | 0.030 |
Why?
|
| Mammals | 1 | 2000 | 1143 | 0.030 |
Why?
|
| Mitomycin | 4 | 1987 | 259 | 0.030 |
Why?
|
| Drosophila Proteins | 2 | 2009 | 1703 | 0.030 |
Why?
|
| Isotopes | 1 | 1993 | 124 | 0.030 |
Why?
|
| RNA Precursors | 1 | 1994 | 208 | 0.030 |
Why?
|
| Heat-Shock Proteins | 1 | 1997 | 822 | 0.030 |
Why?
|
| 5-Methylcytosine | 1 | 1994 | 154 | 0.030 |
Why?
|
| Terminator Regions, Genetic | 1 | 1993 | 28 | 0.030 |
Why?
|
| Drug Resistance, Microbial | 3 | 1998 | 862 | 0.030 |
Why?
|
| DNA Modification Methylases | 1 | 1994 | 206 | 0.030 |
Why?
|
| Genes, MHC Class I | 1 | 1993 | 258 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 1996 | 1547 | 0.030 |
Why?
|
| DNA, Recombinant | 1 | 1993 | 476 | 0.030 |
Why?
|
| Surface Properties | 2 | 2008 | 1184 | 0.030 |
Why?
|
| Cadmium | 1 | 1993 | 212 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1996 | 794 | 0.030 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 1993 | 249 | 0.030 |
Why?
|
| Ribonucleoproteins | 1 | 1994 | 381 | 0.030 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1993 | 337 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2002 | 4328 | 0.030 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 1994 | 371 | 0.020 |
Why?
|
| Alkylation | 3 | 1998 | 86 | 0.020 |
Why?
|
| Amino Acid Isomerases | 1 | 1990 | 34 | 0.020 |
Why?
|
| Codon | 1 | 1993 | 611 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1997 | 2649 | 0.020 |
Why?
|
| Cell Line, Tumor | 3 | 2017 | 16689 | 0.020 |
Why?
|
| Bacteriophages | 1 | 1994 | 356 | 0.020 |
Why?
|
| Operon | 2 | 1989 | 363 | 0.020 |
Why?
|
| Taq Polymerase | 1 | 1990 | 19 | 0.020 |
Why?
|
| Proline | 1 | 1991 | 458 | 0.020 |
Why?
|
| Uracil | 2 | 2001 | 165 | 0.020 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2009 | 121 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2003 | 4042 | 0.020 |
Why?
|
| Macromolecular Substances | 2 | 2008 | 1454 | 0.020 |
Why?
|
| Metalloproteins | 1 | 1989 | 100 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 1997 | 4740 | 0.020 |
Why?
|
| Phosphorylation | 2 | 1992 | 8436 | 0.020 |
Why?
|
| Protons | 1 | 1993 | 1127 | 0.020 |
Why?
|
| Diffusion | 1 | 2009 | 833 | 0.020 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 1990 | 323 | 0.020 |
Why?
|
| Genome | 2 | 2009 | 1808 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 14722 | 0.020 |
Why?
|
| Single-Strand Specific DNA and RNA Endonucleases | 1 | 1986 | 31 | 0.020 |
Why?
|
| Nucleotidases | 1 | 1986 | 31 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2008 | 683 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2005 | 19905 | 0.020 |
Why?
|
| Biotransformation | 1 | 1986 | 168 | 0.020 |
Why?
|
| Guanosine | 1 | 1986 | 61 | 0.020 |
Why?
|
| Bacteriophage lambda | 1 | 2006 | 147 | 0.020 |
Why?
|
| Cell Survival | 1 | 2016 | 5882 | 0.020 |
Why?
|
| Cell Membrane | 2 | 2006 | 3748 | 0.020 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2009 | 407 | 0.020 |
Why?
|
| Cell Division | 2 | 2004 | 4568 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2006 | 411 | 0.020 |
Why?
|
| Leukemic Infiltration | 1 | 2004 | 48 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2004 | 180 | 0.010 |
Why?
|
| Mitochondria, Liver | 1 | 2004 | 187 | 0.010 |
Why?
|
| Monte Carlo Method | 1 | 2009 | 1254 | 0.010 |
Why?
|
| Virus Integration | 1 | 2005 | 299 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 1986 | 865 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2006 | 10943 | 0.010 |
Why?
|
| Liposomes | 1 | 2006 | 759 | 0.010 |
Why?
|
| Anti-HIV Agents | 1 | 1998 | 4256 | 0.010 |
Why?
|
| Female | 3 | 2017 | 380194 | 0.010 |
Why?
|
| Water | 2 | 1998 | 1395 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2017 | 6544 | 0.010 |
Why?
|
| Deoxycytidine | 2 | 1997 | 826 | 0.010 |
Why?
|
| Endosomes | 1 | 2004 | 520 | 0.010 |
Why?
|
| Cytosine Deaminase | 1 | 2001 | 68 | 0.010 |
Why?
|
| HIV Infections | 1 | 2007 | 16718 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9438 | 0.010 |
Why?
|
| DNA Replication | 1 | 2008 | 1399 | 0.010 |
Why?
|
| Deuterium | 1 | 2000 | 101 | 0.010 |
Why?
|
| Nitrogen Isotopes | 1 | 2000 | 84 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2004 | 2085 | 0.010 |
Why?
|
| Renin | 1 | 2002 | 642 | 0.010 |
Why?
|
| X-Rays | 1 | 2001 | 301 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2016 | 19229 | 0.010 |
Why?
|
| Thymine | 1 | 1999 | 68 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 2000 | 467 | 0.010 |
Why?
|
| Male | 1 | 2017 | 350118 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 2003 | 957 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2001 | 1095 | 0.010 |
Why?
|
| Deoxyribonucleotides | 1 | 1998 | 42 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2016 | 9274 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2004 | 2716 | 0.010 |
Why?
|
| Spectrum Analysis | 1 | 2001 | 454 | 0.010 |
Why?
|
| Crystallography | 1 | 1998 | 111 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2016 | 11483 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2006 | 2699 | 0.010 |
Why?
|
| Virus Replication | 1 | 2005 | 2534 | 0.010 |
Why?
|
| RNA Interference | 1 | 2006 | 2889 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 1990 | 4149 | 0.010 |
Why?
|
| Organometallic Compounds | 1 | 2001 | 665 | 0.010 |
Why?
|
| Lyases | 1 | 1996 | 41 | 0.010 |
Why?
|
| Chemistry | 2 | 1987 | 352 | 0.010 |
Why?
|
| Mice, Knockout | 2 | 2003 | 14557 | 0.010 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 1997 | 189 | 0.010 |
Why?
|
| Chemical Phenomena | 2 | 1987 | 518 | 0.010 |
Why?
|
| Propylene Glycols | 1 | 1996 | 92 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 1997 | 438 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2004 | 2382 | 0.010 |
Why?
|
| Hydrogen | 1 | 1996 | 164 | 0.010 |
Why?
|
| Ribonucleoprotein, U2 Small Nuclear | 1 | 1994 | 21 | 0.010 |
Why?
|
| Oligoribonucleotides | 1 | 1994 | 51 | 0.010 |
Why?
|
| Ribonucleoprotein, U1 Small Nuclear | 1 | 1994 | 36 | 0.010 |
Why?
|
| NF-kappa B p52 Subunit | 1 | 1993 | 35 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2009 | 8428 | 0.010 |
Why?
|
| Polydeoxyribonucleotides | 1 | 1994 | 127 | 0.010 |
Why?
|
| Solutions | 1 | 1993 | 426 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 1993 | 256 | 0.010 |
Why?
|
| Computer Graphics | 1 | 1995 | 361 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1997 | 13102 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 1990 | 7181 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 1993 | 898 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2000 | 1708 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1993 | 2255 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 18029 | 0.010 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 1990 | 105 | 0.010 |
Why?
|
| Neisseria meningitidis | 1 | 1990 | 109 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 1996 | 1701 | 0.010 |
Why?
|
| Dithionitrobenzoic Acid | 1 | 1989 | 21 | 0.010 |
Why?
|
| Operator Regions, Genetic | 1 | 1989 | 33 | 0.010 |
Why?
|
| Iodoacetamide | 1 | 1989 | 35 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 1993 | 1060 | 0.010 |
Why?
|
| Deoxycytosine Nucleotides | 1 | 1987 | 14 | 0.000 |
Why?
|
| Spectrophotometry | 1 | 1987 | 313 | 0.000 |
Why?
|
| Spectrophotometry, Infrared | 1 | 1986 | 114 | 0.000 |
Why?
|
| Erythrocytes | 1 | 1996 | 2455 | 0.000 |
Why?
|
| Calcium | 1 | 1999 | 5756 | 0.000 |
Why?
|
| Cell Nucleus | 1 | 1994 | 2969 | 0.000 |
Why?
|
| DNA Transposable Elements | 1 | 1989 | 748 | 0.000 |
Why?
|
| Fourier Analysis | 1 | 1986 | 447 | 0.000 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1996 | 3617 | 0.000 |
Why?
|
| Stem Cells | 1 | 1997 | 3567 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1987 | 2557 | 0.000 |
Why?
|
| Mass Spectrometry | 1 | 1987 | 2203 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1996 | 8949 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1993 | 10180 | 0.000 |
Why?
|
| Pregnancy | 1 | 1996 | 29144 | 0.000 |
Why?
|